{
"NDC": {
"NDCCode": "75987-150-03",
"PackageDescription": "3 VIAL, SINGLE-DOSE in 1 CARTON (75987-150-03) / 10 mL in 1 VIAL, SINGLE-DOSE (75987-150-01) ",
"NDC11Code": "75987-0150-03",
"ProductNDC": "75987-150",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Uplizna",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Inebilizumab",
"DosageFormName": "INJECTION",
"RouteName": "INTRAVENOUS",
"StartMarketingDate": "20200611",
"EndMarketingDate": null,
"MarketingCategoryName": "BLA",
"ApplicationNumber": "BLA761142",
"LabelerName": "Horizon Therapeutics USA, Inc.",
"SubstanceName": "INEBILIZUMAB",
"StrengthNumber": "10",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "CD19-directed Antibody Interactions [MoA], CD19-directed Cytolytic Antibody [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-12-24",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20200611",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}